Navigation Links
Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
Date:9/8/2010

hibits equivalent brain uptake to that of its parent molecule, 11C-Pittsburgh compound B, while also providing high test-retest replicability and potentially greater accessibility for clinical and research use," said Rik Vandenberghe, MD, PhD, Neurology Department, University Hospitals Leuven, Belgium.

"The importance of this study is underscored by the fact that it represents the first direct comparison of 11C-Pittsburgh compound B (which is also known as PiB) to a true analog of this compound," commented William E. Klunk, MD, PhD, professor of Psychiatry and Neurology at the University of Pittsburgh. The current study shows that, in addition to providing equivalent efficacy, flutemetamol actually offers greater test-retest reliability than has been reported with PiB. Flutemetamol thus appears to be a viable and practical alternative to PiB."

The study was also the subject of Dr. Bill Jagust's editorial in the same issue of the Annals of Neurology, which provides further analysis of the study.

The ongoing flutemetamol phase 3 trial program is a series of multicenter studies that include patients who consent to brain biopsy or to post-mortem assays to determine the level of association between imaging detection of amyloid and histopathology findings. A separate study is underway in patients with MCI who may progress to AD. The trials have already commenced with recruitment and imaging of patients at multiple sites in the USA and Europe.

About GE Healthcare

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we part
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
6. IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
7. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
8. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
9. ORTHO EVRA(R) Prescribing Information Updated
10. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
11. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PLEASANTON, Calif. , Nov. 26, 2014  Thoratec ... in device-based mechanical circulatory support therapies to save, support ... participating in two upcoming investor conferences. On ... 26 th Annual Piper Jaffray Healthcare Conference.  ... will provide an update on the company beginning at ...
(Date:11/26/2014)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... Products®," today announced the closing of Perrigo,s previously announced ... ordinary shares at a public offering price of $152.00 ... to purchase up to an additional 888,157 ordinary shares ... as representatives of the several underwriters. ...
(Date:11/26/2014)... , Nov. 26, 2014 Lexicon Pharmaceuticals, ... the completion of previously announced concurrent financing transactions ... fees and estimated offering expenses, Lexicon anticipates net ...  The transactions consisted of: , a ... pursuant to a registration statement that has been ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... announced that it has filed a lawsuit in the Netherlands ... Labem, Czech Republic, where Dr. Cervinka is head of the ... conducted at the Masaryk Hospital, in which Dr. Cervinka was ... stent with a bare metal stent for treatment of a ...
... CSL Behring today announced the development ... absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin ... high degree of accuracy and precision. The new PK ... by which SC IgG is transported after it is ...
Cached Medicine Technology:OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation 2OrbusNeich Files Lawsuit Against Dr. Pavel Cervinka for Defamation 3New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies 2New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies 3New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies 4New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies 5New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies 6
(Date:11/28/2014)... November 29, 2014 TideStore.com , has ... new dresses, shoes and other fashion items recently. Its 2014 ... site. , The special offer is valid during Nov. ... tops, stylish women outwears, charming dresses, shining prom shoes, essential ... leading online store offering many trendy clothes and fashion accessories. ...
(Date:11/28/2014)... 2014 The report “Poxvirus Infections ... the therapeutic development for Poxvirus Infections, complete with ... drug target, mechanism of action (MoA), route of ... updates, and featured news and press releases. It ... development for Poxvirus Infections and special features on ...
(Date:11/28/2014)... sells cheap tall cocktail dresses worldwide and ... there is a new collection of tall cocktail dresses ... at very low prices. It is really worthy to ... by UWDress.com , UWDress.com is one of the most ... has the power to ensure customer satisfaction. Now, the ...
(Date:11/28/2014)... 29, 2014 Angelweddingdress.com, a world-famous ... collection of Blue Color Styles of ... up to 80% off and free shipping on ... discounted blue bridesmaid dresses for less at the ... Angelweddingdress.com is famous as a reliable dress supplier ...
(Date:11/28/2014)... New York, NY (PRWEB) November 28, 2014 ... ground-breaking physical therapy techniques such as Dynamic Neuromuscular ... therapy, and gait/motion analysis. After moving to upgraded ... sports and running clinic. Now, owner Dr. Lev ... movement performance and injury prevention lab in the ...
Breaking Medicine News(10 mins):Health News:2014 Special Monday Sales from TideStore.com 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 2Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 3Health News:Poxvirus Infections and Vestibular Diseases Pipeline Market Drugs and Companies Review H2 2014 4Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:Blue Color Styles of Bridesmaid Dresses from AngelWeddingDress.com are Available Now With Big Discounts 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 2Health News:New York Dynamic Neuromuscular Rehabilitation Opens Nation's Most Advanced Movement Performance and Injury Prevention Lab 3
... ANN ARBOR, Mich. -- Only about one in five young ... the 2009-2010 swine flu epidemic, according to a University of ... X. But about 65 percent were at least moderately ... were following the issue very or moderately closely. Using ...
... Marriage offers few well-being advantages compared to living together, a ... benefits of marriage diminish over time, while unmarried couples who ... data from 2,737 single men and women who took part ... those people, 896 married or moved in with a partner ...
... Reporter , MONDAY, Jan. 23 (HealthDay News) -- Shedding some light ... finds that parts of your immune system ramp up when you ... this effect of stress may make you sick, but the activated ... body -- have been linked to conditions such as diabetes and ...
... MONDAY, Jan. 23 (HealthDay News) -- Although many people believe ... the opposite may be true with traumatic brain injuries. ... injury in children as young as 2 years, and found ... for some time. However, the researchers also found that recovery ...
... more than 40 years, scientists and physicians have thought eating ... disease of the large intestine in which pouches develop in ... people reveals the opposite may be true. The study, ... Chapel Hill School of Medicine , found that consuming a ...
... A new study published online today in the ... finds hospitals participating in a regional collaborative of the ... (ACS NSQIP), achieved substantial improvements in surgical outcomes, such ... surgical site infections. The collaborative also saved $2,197,543 per ...
Cached Medicine News:Health News:Generation X: How young adults deal with influenza 2Health News:Living Together May Be Mentally Healthier Than Marriage: Study 2Health News:Study Shows How Stress Triggers Immune System 2Health News:Study Shows How Stress Triggers Immune System 3Health News:Severe Brain Injury When Young May Have Long-Term Effects 2Health News:Severe Brain Injury When Young May Have Long-Term Effects 3Health News:Severe Brain Injury When Young May Have Long-Term Effects 4Health News:Diets high in fiber won't protect against diverticulosis 2Health News:Regional surgical quality collaborative significantly improves surgical outcomes and reduces cost 2Health News:Regional surgical quality collaborative significantly improves surgical outcomes and reduces cost 3
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
... facilitates fast and effective resection of meniscal ... meniscal rim. The flat, crescent-shaped tip has ... the tightest joint spaces. Made in the ... of engineering experience in arthroscopy hand instrument ...
... facilitates fast and effective resection of meniscal ... meniscal rim. The flat, crescent-shaped tip has ... the tightest joint spaces. Made in the ... of engineering experience in arthroscopy hand instrument ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
Medicine Products: